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A B S T R A C T
The mineral metabolism disorder is the most influential factor of the morbidity and mortality incidence of haemo-
dialysis uremic patients. The second most influential factor is the infection, which is the most frequent complication with
an undesirable outcome. In recent times, the relation of the increased serum calcium and phosphorus level on the one
hand, and the morbidity and mortality of that population in case on the other, has been observed. However, insufficient
professional and scientific thought has been given to the relation of the lower serum levels of the aforementioned miner-
als and the morbidity and mortality incidence. We have researched the relation between lower serum calcium level (hypo-
calcaemia) and the complication incidence, especially infection. Throughout the time period of 18 months, 120 haemo-
dialysis uremic patients were observed and 76 (63.3%) of them had serum calcium level below the lower threshold of
referent values (9.0–9.5 mg/dL). In the patients with a lower serum calcium level (hypocalcaemia) a significant infection
incidence (c2=3.99; p=0.0468), a significant sepses incidence (c2=8.016; p=0.04), a significant total complication inci-
dence (p<0.05) were determined, as well as a higher vascular access local infection incidence, but without statistically
significant research results of this relation (c2=0.098; p=0.7598). We are of the belief that the incidence of the vascular
access local infection should be examined on a greater number of patients; therefore, the significance of the examined re-
lation in such an instance would be expected. The total infection incidence in all 120 observed patients is 3.8 for 100
months. It is to be concluded that the research findings indicate the association regarding the appearance of low serum
calcium concentration (hypocalcaemia) and an increased complication incidence, especially the inflammation that leads
to the requirement of further research in order to decrease morbidity, and consequently also the mortality of the observed
population of patients by means of programmed therapy approach.
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Introduction
The mortality rate of haemodialysis uremic patients
is even nowadays unacceptably high, and it is in many
ways higher than in any other human population, and al-
most 20% of them die1–3 annually, in spite of better tech-
nology regarding haemodialysis and a better understand-
ing of biochemistry and pathophysiology in the organism
of patients with terminal kidney failure4–9. Formerly,
upon the implementation of haemodialysis in the treat-
ment of patients with kidney failure, more attention was
paid to the influence on the organs and to the skeletal
system10 whereas lately, more attention is paid to the in-
fluence of such condition to the general morbidity and
mortality11–14. The research attention is more directed
towards the determination of risk factors, which are re-
sponsible for the morbidity and mortality. Block et al.1
have put these risks factors into two different groups.
The first group is comprised of those, which cannot be in-
fluenced, and according to Block et al.1 they include de-
mographic factors, concomitant states and nutritive in-
sufficiency. The second group is comprised of serum
haemoglobin concentration, intensity and the scope of di-
alysis, as well as mineral disorders metabolism, such as
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calcium and phosphorus. According to Block et al.1 these
mortality risk factors can be influenced, and in such a way
decreasing morbidity and mortality. We are of the opinion
that alongside the mentioned risk factors in the second
group, that is, among those that can be influenced, the se-
rum albumin level should also be included15,16.
Up till recent times, minute attention was paid to the
mineral metabolism disorders5 in the research of the
morbidity and mortality risk factors in patients with ter-
minal renal insufficiency, even though the mineral disor-
der, alongside with infection, is the most efficient factor
in morbidity, as well as a general and cardiovascular mor-
tality incidence of such patients9,11,17–20. The second most
influential factor in the morbidity and mortality inci-
dence is infection. Debates are held regarding the way in
which the infection could influence the morbidity and
mortality, as well as the mineral metabolism disorder,
that is, calcium and phosphorus. An adequate explana-
tion still awaits to be given.
The subject of this research is the relation between
the serum calcium concentration and the complication
incidence, especially the infection of the haemodialysis
uremic patients. According to Block et al.1 the conception
serum mineral concentration disorder belongs to the cor-
rectable risk factors for morbidity and mortality. The aim
is to study the relation between the low serum calcium
concentration (hypocalcaemia) and the complication in-
cidence, particularly of the infection as the most frequent
complication and the most influential factor on morbid-
ity and mortality of this population of patients.
Patients and Methods
120 haemodialysis uremic patients treated in the dial-
ysis ward of the University Hospital Mostar, were in-
cluded into this study. The aim of the research was to de-
termine the relation between the serum calcium level
and the complication incidence, with special reference to
the relation with infections. The patients were chosen
randomly, and only those patients with established AV-
-fistulae on the forearm, and who at the moment of be-
ginning of the research did not exhibit any signs of local
infection of the vascular access nor clinical symptoms
nor laboratory findings, which would confirm sepses. In
addition, only those patients who at the moment of com-
mencing the research did not have any signs of some
other complication, which would put the vascular access
and the life of a patients in danger, were chosen for the
research in case. The patients were observed throughout
the period of 18 months and all of them, alongside other
blood tests in time intervals of 3 month, underwent rele-
vant blood tests for examining the relation between the
infection and the mineral disorder, as well as for the illus-
tration of the observed patients’ biological status of the
organism.
Throughout the handling of the patients, the referent
values of the serum calcium level, as well as phosphorus
have been set, with a slight deviation, as it was done by
Block and associates (2004) in their study. The referent
calcium levels in this study range from 9.0 mg/dL to 9.9
mg/dL, and phosphorus levels range from 4.0 mg/dL to
5.0 mg/dL. It should be pointed out that various authors
in their reports state the calcium and phosphorus refer-
ent values in a vast range, which for calcium are gener-
ally from 8.5 mg/dL to 10.5 mg/dL, and from 3.5 mg/dL to
6.5 mg/dL for phosphorus.
Research was conducted in such a way that the values
of serum calcium and phosphorus levels, determined in
each individual patient, were compared to the complica-
tion incidence, to the incidence of total infection, sepses
and vascular access infection. In the illustration of the
infection incidence, the incidence of the infection episode
was also determined in each individual patient. In to-
day’s understanding of the relation between the serum
values of the mentioned parameters the incidence of
pathological changes in the organism, the accepted point
of view is that there is no separate impact of the serum
level of each examined parameter (calcium, phosphorus
and parathormon) onto the biological functions of a
healthy organism, yet their influence onto the functions
of the organism with chronic renal failure has been par-
ticularly accentuated. The change of the serum level of
one parameter causes the changes of the other two pa-
rameters, with subsequent effects on the organs and sys-
tems. Due to the network of serum relations and the ef-
fect on the organism of these three parameters, we are of
the opinion that the research results of the relation be-
tween calcium metabolism disorder and complication in-
cidence in haemodialysis uremic patients can also indi-
rectly represent an illustration of phosphorus and para-
thormon disorders.
Descriptive statistics have been used in the basic eval-
uation of the numerical data in order to determine the
mean values, the standard deviation and the span. Cate-
gorical data has been shown by the frequency of appear-
ance as well as their proportion, that is, their percentage.
In the statistical analysis we have used the Chi-square
test. The statistical significance has been regarded on the
level of importance p0.05. that is with 95% of relevance
threshold. For the analysis of the collected data we have
used the application program Statistics version 8.0. whe-
reas the graphic presentation has been made in Excel.
Results
Table 1 illustrates the distribution of patients regard-
ing the age and sex, whereas pathological conditions
which caused terminal kidney failure (ESRD) are shown
in Table 2. There it can be seen that the most common
cause for kidney failure was hypertensive nephrosclero-
sis, and then interstitial nephritis followed by glomero-
lonephritis, whereas other pathological conditions were
represented less.
Table 3 shows the co-morbidity again. Some of these
co-morbid conditions, such as diabetic nephropathy, con-
tribute as a self-acting agent to actively increase the mor-
bidity and mortality of haemodialysis uremic patients.
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Table 4 illustrates the primary locations of infection
as well as the number of patients with the infection. In
the right column of the table, the number of patients
with an isolated micro-organism of infection, that is, the
kind of the micro-organism is shown. Therefore, it is evi-
dent that in some infectious patients the micro-organism
is not isolated, whereas clinical signs and laboratory re-
sults have confirmed the presence of the infection. As it
has become apparent from the shown data, the respira-
tory infection is the most common infection present in
observed patients. It is followed by vascular approach in-
fection, that is, localised infection of the vascular ap-
proach, which also represented the original point of
sepses alongside other points mentioned in the table.
Table 5 illustrates the minimum, the maximum, and
the mean values, as well as the standard deviation of the
observed serum level variables in all 120 patients. The
table clearly shows that the mean value of serum calcium
concentration is 8.94 mg/dL, the lowest value is 5.24
mg/dL and the highest is 13.12 mg/dL, whereas the stan-
dard deviation value is 0.84 mg/dL. The distribution of
patients according to the serum calcium level, as well as
the relation between the serum level and the inflamma-
tion incidence are illustrated in Table 6. From the first
column in Table 6, it is evident that 76 (63.3%) patients
had a serum calcium level below the lower threshold of
the set referent values (9.0 mg/dL – 9.9 mg/dL), 39
(32.5%) of them within the threshold, and 5 (4.2%) of
them above those values. In addition, it is evident from
the same table that 48 (40.0%) out of the 120 (100.0%)
observed patients had an infection. Out of those 48
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TABLE 1
DISTRIBUTION OF PATIENTS ACCORDING TO AGE AND SEX
Age (years) Male Female Total
11–20 – 1 1
21–30 3 – 3
31–40 8 6 14
41–50 10 7 17
51–60 23 13 36
61–70 10 7 17
71–80 15 13 28
81–90 – 3 3
91–100 1 – 1
Total 70 50 120
TABLE 2
PATHOLOGICAL CONDITIONS WHICH CAUSED TERMINAL
KIDNEY FAILURE (ESRD)
















Cardiovascular diseases 51 42.5




THE ILLUSTRATION OF THE PRIMARY LOCATION OF INFECTION AND THE KINDS OF ISOLATED MICRO-ORGANISMS IN











15 Staphylococcus epidermidis 4 26.6
Staphylococcus aureus 6 40.0
Infection of respiratory
system
16 Streptococcus pneumoniae 1 6.2
Klebsiella pneumoniae 2 12.4
Infection of urinary system
9 Escherichia coli 3 33.3
Enterococcus species 2 22.2
Infection of skin and soft
tissues
4 Streptococcus pyogenes 1 25.0
Streptococcus aureus 2 50.0
Staphylococcus epidermidis 1 25.0
Endocarditis 2 Staphylococcus epidermidis 2 100.0
Others 2 – 2 –
Total 48 – 24
(100.0%) patients with infection, 39 (81.25%) patients
had a serum calcium level below 9.0 mg/dL, 9 (18.75%) of
them within referent values, whereas none of the pa-
tients with an infection had the serum calcium level
above upper threshold of referent values, that is, above
9.9 mg/dL. The results of the comparison of the hypocal-
caemia incidence between the patients with an infection
and those without an infection are given in the appendix
to the Table 6. It is evident that there is a significant dif-
ference regarding the frequency of inflammation in pa-
tients with a serum calcium level below 9.0 mg/dL and
those above 9.9 mg/dL (c2=3.99, p=0.0468). Therefore,
in the patients with a serum calcium level below 9.0
mg/dL, the infection is much more frequent.
Table 7 illustrates the relation between the serum cal-
cium level and sepses. There it is evident that out of 120
(100.0%) patients, 40 (33.3%) of them had sepses. Out of
those 40 (100.0%) patients with sepses, 32 (80.0%) pa-
tients had a serum calcium level below the lower thresh-
old for the referent calcium levels, that is, below 9.0
mg/dL, and 8 (20.0%) of them had serum calcium level
within referent values, whereas none of the patients be-
longing to the group of patients with an increased serum
calcium level, in other words, above 9.9 mg/dL, had
sepses. The results of the comparison of the hypocal-
caemia incidence between the patients with sepses and
those without are illustrated in the appendix of Table 7.
It is evident that there is a significant difference in the
frequency of sepses in those patients with a serum cal-
cium level lower than 9.0 mg/dL, those with the level be-
tween 9.0 mg/dL and 9.9 mg/dL (referent values), as well
as those above 9.9 mg/dL (c2=8.016, p=0.04). The sepses
incidence is considerably higher in the patients with a
lower serum calcium level than in those patients with a
higher level.
The Relation between the serum calcium level and in-
cidence, except for infection and other complications is
shown in Table 8. As it is apparent from the aforemen-
tioned table, complications arose in 59 (49.16%) out of
120 (100.0%) patients. 44 (74.57%) of the 59 (100.0%) pa-
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TABLE 5
RESULTS OF BLOOD TESTS (THE MAXIMUM, THE MINIMUM AND THE MEAN VALUES AS WELL AS STANDARD DEVIATION)
OF VARIABLES
Variables X Minimum Maximum Standard deviation
Serum Calcium mg/dL 8.94 5.24 13.12 0.84
Serum proteins g/L 63.46 30.6 85.1 6.93
Serum albumins g/L 36.6 20.2 50.1 3.8
C-reactive proteins mg/L 12.31 0.1 191.8 21.05
Serum ferritin mg/L 169.05 4.43 1119 206.58
Haemoglobin g/L 102.61 59.0 160 17.83
Urea prior to dialysis mmol/L 21.3 5.2 44 5.16
TABLE 6
THE DISTRIBUTION OF PATIENTS ACCORDING TO THE SERUM CALCIUM LEVEL AND THE RELATION BETWEEN THE SERUM




Total of patients With infection Without infection
Patients with the infection
The number of infection episodes
1 2
<7.0 17 8 9 8 2
7.0–7.9 15 11 4 11 3
8.0–8.9 44 20 24 20 2
9.0–9.9 39 9 30 9 1
10.0–10.9 5 – 5 – –
>11.0 – – – – –
Total 120 (100%) 48 (40%) 72 (80%) 48 8
Serum calcium
level (mg/dL)
The number of patients
with an infection
The number of patients





tients with complications had a serum calcium level be-
low 9.0 mg/dL, whereas 15 (25.42%) of them had a cal-
cium level within the referent values, that is, between 9.0
mg/dL and 9.9 mg/dL. The difference is 49.15% and it is
statistically significant (p<0.05).
15 (12.5%) patients out of 120 (100.0%) exhibited an
inflammation of the vascular access. The relation be-
tween the vascular access inflammation incidence and
the serum calcium level was observed as shown in Table
9, 12 (80.0%) out of 59 (100.0%) patients with the infec-
tion of vascular access had, as shown in Table 9, a serum
calcium level below 9.0 mg/dL, and 3 (20.0%) of them had
a serum calcium level within the referent values, whe-
reas the inflammation of this localisation and the type
was not exhibited among the patients with a serum cal-
cium level above 9.9% mg/dL. In this relation it has been
established that the inflammation of the vascular access
was exhibited only among the patients with hypocalcae-
mia, and not even once in those patients with hypercal-
caemia. The results of the comparison of the vascular ac-
cess inflammation incidence difference between the pa-
tients with a serum calcium level below 9.0 mg/dL and
those patients with serum calcium level above 9.9 mg/dL
are shown in the appendix of Table 9. There is no signifi-
cant difference between the observed groups (c2=0.098;
p=0.7598).
Discussion
The incidence of kidney diseases is increasing and
there are more patients with terminal kidney failure7 and
the mortality of haemodialysis uremic patients is high1–3
even today. In the last decade, research has been con-
ducted in order to establish and determine the risk fac-
tors for such high morbidity and mortality11–14. There are
numerous factors that participate in the increased mor-
bidity and mortality of dialysis patients, and lately a lot
of attention has been placed on infections and the min-
eral metabolism disorder. In recent times, a lot of atten-
tion has also been given to the research of the influence
of increased serum calcium and phosphorus levels onto
the morbidity and mortality of this population of pa-
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TABLE 7




With sepses Without sepses Total %
<7.0 6 11 17 64.7
7.0–7.9 8 7 15 46.7
8.0–8.9 18 26 44 59.1
9.0–9.9 8 31 39 74.5
10.0–10.9 – 5 5 100.0
>11.0 – – – –
Total 40 (33.3%) 80 (66.6%) 120 (100.0%)
Serum calcium
level (mg/dL)
Number of patients with sepses Number of patients without sepses c2 p
<9.0 32 44
9.0–9.9 8 32 8.016 0.04
>9.9 – 5
TABLE 8













<7.0 8 – – – – – 8
7.0–7.9 11 3 – – – – 14
8.0–8.9 20 1 – – – 1 22
9.0–9.9 9 4 – – 1 1 15
10.0–10.9 – – – – – – –
>11.0 – – – – – – –
Total 48 8 0 0 1 2 59
tients. In dissecting such a relation, an issue of establish-
ing the conditions and parameters that cause the oscilla-
tion of serum levels and mineral disorders arise, which
then has an effect on morbidity and mortality. Particu-
larly these moments, which alongside the conditions for
terminal kidney failure cause the mineral metabolism
disorder, which establish the basis for the increased mor-
bidity and mortality by far. These are the risks factors
that Block et al.1 mention, which according to them can
be influenced, and consequently, reduce morbidity and
mortality.
The influence of the serum calcium and phosphorus
concentration onto the frequency of complications in di-
alysis patients, as the most influential factor, did not gain
the position it deserves in research. The question arises,
whether, and in what way, does the serum calcium and
phosphorus disorder in dialysis patients influence the
complications’ occurrence, and consequently infection,
as the most frequent complication, which is the second
most influential factor in the high morbidity and mortal-
ity of this population of patients. Accordingly, the second
most influential factor in morbidity and mortality is in-
fection. The discussions regarding the manner in which
the infection could affect the morbidity and mortality, as
well as the mineral metabolism disorders are held. The
issue is whether the infection and the mineral metabo-
lism disorder, as the two most influential factors in mor-
bidity and mortality incidence, act in synergy. Whether
mineral metabolism disorders, in this case calcium and
phosphorus, create suitable conditions for infection oc-
currence, which would then lead to an increased morbid-
ity and mortality, is also one of the issues. Whether, and
in what stage, do these two parameters, that is, the infec-
tion and the calcium and phosphorus metabolism disor-
der appear in unison by chance, or is there any cause-ef-
fect relation in the occurrence and interaction of these
two parameters in this population of patients? Whether
the regulating serum calcium and phosphorus concentra-
tion could reduce the infection incidence, as well as the
morbidity and mortality? What is the relation between
these two most influential factors, that is, mineral me-
tabolism disorder and infection as the most frequent
complications for morbidity as well as total and cardio-
vascular mortality of dialysis patients, are some of the is-
sues only to be instigated in practice and science. There
are certain indications that open the possibility of a uni-
son effect of infection and serum calcium disorders onto
the morbidity and mortality of this population of pa-
tients17,18,.21–24 and there is a presumption that it is just a
case of accompanying simultaneous occurrences of these
phenomena. Young et al.9 determined a higher mortality
incidence in patients with extreme calcium concentra-
tion values in dialysis. In this study, we would like to de-
termine the relation between the serum calcium concen-
tration and total complication incidence, total inflamma-
tion, sepses and vascular access localised infection, that
is to determine whether the changes of serum calcium
concentration in the observed population of patients in-
fluence the complication incidence, to what degree, and
especially that of infection. Is the simultaneous manifes-
tation of these two parameters throughout the haemo-
dialysis treatment, if it was successfully proven by this
study, coincidental findings or does this imply a possible
connection between the serum calcium concentration
changes and complication incidence?
The research topic of this study is therefore the rela-
tion of disorders between the serum calcium level and
the complication incidence in dialysis patients, with a
special reference to infections as the most frequent com-
plication. It is surprising that a relation between the low
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TABLE 9




Number of patients Patients with an infection
With infection of the
vascular access
Without infection of the
vascular access
the number of infection episodes
1 2
<7.0 3 14 1 1
7.0–7.9 5 10 4 –
8.0–8.9 4 40 4 –
9.0–9.9 3 36 3 –
10.0–10.9 – 5 – –
>11.0 – – – –
Total 15 105 12 1
Serum calcium
level (mg/dL)
Patients with an infection
of the vascular access
Patients without an infection





serum calcium concentration and the morbidity and mor-
tality incidence has still remained insufficiently recog-
nised in practice, and consequently subjected to thor-
ough research. Leafing through medical journals we have
come across to only one article that deals with such a re-
lation. Gulati et al.24 in their research determined a sta-
tistically significant relation of hypocalcaemia and the
infection incidence, and they considered it, besides other
things, the infection risk factor. They also mention that
they had not come across any other published scientific
articles that deal with such a relation. All the attention is
directed to the relation between hypercalcaemia and
morbidity and mortality6,7,11,17,18,20–22. Foley et al.25 in
their early research found a significantly increased mor-
bidity and mortality ratio even in the dialysis patients
with lower serum calcium levels. Nakai et al.26 and Osawa27
whose work is much more recent also mention this.
Thus, in the aforementioned circumstances, both in pra-
ctice and in science regarding the comprehension of the
relation between low serum calcium level and high mor-
bidity and mortality incidence in the observed population
of patients in particular, gave us an incentive, amongst
other things, to subject such a relation to research.
It is evident from Table 5 that there is a great differ-
ence between the highest and the lowest serum calcium
value in observed patients, where the lowest value was
5.24 mg/dL and the highest 13.12 mg/dL. It has been de-
termined that 39 (32.5%) of the observed patients had a
serum calcium concentration within referent values, that
is, between 9.0 mg/dL and 9.9 mg/dL, whereas 76 (63.3%)
of the patients were below these values, and 5 (4.2%)
were higher than these values. These results are some-
what different from the reports of other authors9,27. It is
important to point out that comparisons are more diffi-
cult due to the differently set of referent values of the cal-
cium throughout the research of other authors. There-
fore, it is apparent that from a therapy approach to the
patients undergoing the programme of chronic haemo-
dialysis, a homeostatic calcium disorder in the sense of
hypocalcaemia should be taken into consideration in or-
der to reduce both morbidity and mortality. Neither sci-
ence nor the practice pay as much attention to this rela-
tion as they should. The change of the serum calcium
concentration was the trigger of the metabolic changes of
other minerals and pathological conditions, hence it de-
serves further studies in determining a therapy approach
to the phenomenon of the mineral metabolism disorder,
both in a sense of hypercalcaemia and hypocalcaemia, in
order to create possibilities to reduce the morbidity and
mortality of haemodialysis uremic patients.
The infection incidence (Table 6) is significantly higher
in patients with hypocalcaemia (c2=3.99; p=0.0468). The
same relation was shown in the relation between the
sepses incidence and serum calcium level, as it was illus-
trated in Table 7; in other words the sepses incidence is
considerably higher in patients with a serum calcium
level below 9.9 mg/dL, than among those patients with a
calcium level above this value (c2=8.016; p=0.04). The
total complication incidence (Table 8), among the pa-
tients with hypocalcaemia is higher than in those pa-
tients with serum calcium level within referent values,
and the difference is 49.15%, which is statistically signifi-
cant (p<0.05). The examined relation between the serum
calcium level and the vascular access local infection inci-
dence illustrates in the same way that infection was
more frequent in patients with hypocalcaemia than in
those patients with a serum level above the upper thres-
hold of the referent values 9.9 mg/dL. However, this dif-
ference is not statistically significant (c2=0.098, p= 0.7598).
The research results in the first three examined relations
that is, the total infection incidence, sepses and total
complications on the one hand, and the calcium level on
the other, showed that hypocalcaemia can be viewed as a
participant in increased morbidity, and consequently in
the mortality of haemodialysis uremic patients. The fact
that the results of the established relation between hypo-
calcaemia and vascular access infec- tion (Table 9), and
the determined difference is apparent, and yet are not
statistically significant, can be supported by the fact that
a small number of cases were taken into the examination
of this relation, in order to determine the real relation
between hypocalcaemia and vascular access local infection
incidence.
At the end of the completed programmed research of
the relation between the serum calcium level and compli-
cations in haemodialysis uremic patients, the concisely
laid out achieved results are as follows:
1. 76 (63.3%) patients had a serum calcium concentra-
tion below the lower threshold of referent values (9.0
mg/dL – 9.9 mg/dL), 39 (32.5%) of them within the
limits, and 5 (4.2%) of them above those values;
2. 48 (40.0%) out of 120 (100.0%) patients had infec-
tion.The infection incidence is significantly higher in
patients with hypocalcaemia (c2=3.99; p=0.0468);
3. Out of 48 (100.0%) patients with infection, 40 (89.6%)
of them had sepses. The sepses incidence is signifi-
cantly higher in patients with hypocalcaemia (c2=
8.016; p=0.04);
4. The incidence of total complications is significantly
higher in patients with hypocalcaemia (p<0.05);
5. The incidence of vascular access infection is significan-
tly higher in patients with hypocalcaemia. However, the
difference is not statistically significant (c2=0.098,
p=0.7598);
6. The total infection incidence in all 120 observed pa-
tients is 3.8 episodes for 100 patients months.
Conclusion
The serum changes and mineral metabolism disorders
are the most prominent factor in the morbidity incidence,
as well as general and cardiovascular mortality of haemo-
dialysis uremic patients. It has been determined that the
complication incidence, especially those of infection is in-
creased in the patients with hypocalcaemia, as the most
frequent and the most influential complication in the in-
creased morbidity and mortality of observed patients.
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ODNOS SERUMSKE RAZINE KALCIJA I INCIDENCIJE KOMPLIKACIJA U BOLESNIKA
LIJE^ENIH KRONI^NOM HEMODIJALIZOM
S A @ E T A K
Poreme}aj metabolizma minerala je najutjecajniji ~imbenik u incidenciji morbiditeta i mortaliteta bolesnika lije~e-
nih kroni~nom hemodijalizom. Drugi je utjecajni ~imbenik upala koja je naj~e{}a i najpogubnija komplikacija. Zadnje je
vrijeme promatran odnos povi{enih serumskih razina kalcija i fosfora s jedne te morbiditeta i mortaliteta s druge strane
u te populacije bolesnika, dok je ipak nedovoljno stru~ne i znanstvene pa`nje posve}eno odnosu ni`e serumske razine
kalcija (hipokalcemija) i incidencije komplikacija, posebno upale. Promatrano je kroz 18 mjeseci 120 bolesnika lije~enih
kroni~nom hemdijalizom i njih 76 (63,3%) je imalo serumsku razinu kalcija ispod donje granice referentnih vrijednosti
(9.0–9,5 mg/dL). U bolesnika s ni`om erumskom razinom kalcija (hipokalcemija) utvr|ena je zna~ajna incidencija upale
(c2=3,99; p=0,0468), zna~ajna incidencija sepse (c2=8,016; p=0,04), zna~ajna incidencija ukupnih komplikacija (p=
0,05), a uo~ena je i ve}a incidencija lokalne upale vaskularnog pristupa, ali bez statisti~ke zna~ajnosti postignutih rezul-
tata ispitivanja tih odnosa (c2=0,098; p=0,7598). Smatramo da je potrebno ispitati incidenciju lokalne upale vaskular-
nog pristupa na ve}em broju bolesnika pa bi tada i u ispitivanju tih odnosa, za o~ekivati je, bila izra`ena statisti~ka
zna~ajnost. Sveukupna incidencija upale u svih 120 promatranih bolesnika je 3,8 na 100 bolesnikovih mjeseci. Zaklju-
~ak: Postignuti rezultati ukazuju na udru`enost u pojavljivanju niske serumske razine kalcija (hipokalcemija) i pove}a-
ne incidencije komplikacija, posebno upale {to ukazuje na potrebu daljnjeg istra`ivanja kako bi se programiranim tera-
pijskim pristupom uspjelo smanjiti morbiditet, a onda i mortalitet promatrane populacije bolesnika.
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